MCID: LVR002
MIFTS: 44

Liver Angiosarcoma malady

Categories: Rare diseases, Cancer diseases, Gastrointestinal diseases, Liver diseases

Aliases & Classifications for Liver Angiosarcoma

About this section

Aliases & Descriptions for Liver Angiosarcoma:

Name: Liver Angiosarcoma 11 13
Angiosarcoma of Liver 11 68
 
Hemangiosarcoma of the Liver 11
Angiosarcoma of the Liver 48

Classifications:



External Ids:

Disease Ontology11 DOID:268
ICD1030 C22.3
NCIt45 C4438

Summaries for Liver Angiosarcoma

About this section
Disease Ontology:11 An angiosarcoma and sarcoma of liver and hemangioma of intra-abdominal structure and Ca liver - primary that is located in the liver.

MalaCards based summary: Liver Angiosarcoma, also known as angiosarcoma of liver, is related to hepatocellular carcinoma and rubella panencephalitis. An important gene associated with Liver Angiosarcoma is KRAS (KRAS Proto-Oncogene, GTPase), and among its related pathways are TP53 network and Inhibition of Ribosome Biogenesis by p14(ARF). Affiliated tissues include the liver, liver and endothelial, and related mouse phenotypes are Decreased cell migration and pigmentation.

Related Diseases for Liver Angiosarcoma

About this section

Diseases related to Liver Angiosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 196)
idRelated DiseaseScoreTop Affiliating Genes
1hepatocellular carcinoma28.0CDK4, CDKN2A, CYP2E1, KRT19, TP53
2rubella panencephalitis10.7KRT19, VIM
3pulmonary venoocclusive disease10.6KRAS, VIM
4familial papillary or follicular thyroid carcinoma10.6KRT19, VIM
5acute sanguinous otitis media10.6KRAS, KRT19
6pterygium colli mental retardation digital anomalies10.6KRAS, NRAS
7brachydactyly, type e210.6KRAS, NRAS
8rad51c-related fanconi anemia10.6KRAS, NRAS
9malignant hyperthermia susceptibility10.5KRAS, TP53
102q33.1 microdeletion syndrome10.5ENO2, VIM
11oligoastrocytoma10.5KRT19, VIM
12sm-ahnmd10.5TP53, VIM
13skin lipoma10.5CDK4, VIM
14vagina sarcoma10.5HRAS, KRAS
15kidney sarcoma10.5TP53, VIM
16eccrine papillary adenoma10.5TP53, VIM
17rectum mucinous adenocarcinoma10.5KRAS, TP53
18glomerulosclerosis10.5HRAS, KRAS
19gonococcal spondylitis10.5HRAS, KRAS
20exstrophy-epispadias complex10.5ENO2, VIM
21skin glomangioma10.4TP53, VIM
22myxosarcoma10.4HRAS, KRAS
23chromosome 7p duplication10.4CDK4, TP53
24melanocytic nevus syndrome, congenital, somatic10.4HRAS, NRAS
25mediastinum teratoma10.4KRAS, TP53
26seminal vesicle chronic gonorrhea10.4HRAS, KRAS
27demyelinating polyneuropathy10.4HRAS, NRAS
28congenital myasthenic syndrome10.4KRT19, TP53
29sublingual gland adenoid cystic carcinoma10.4HRAS, NRAS
30vulvar alveolar soft part sarcoma10.4HRAS, VIM
31coloboma of macula and skeletal anomalies10.4HRAS, NRAS
32trachea adenoid cystic carcinoma10.4HRAS, KRAS
33breast papillary carcinoma10.4HRAS, KRAS
34classic pulmonary blastoma10.4KRAS, TP53
35uterine ligament serous adenocarcinoma10.3HRAS, KRAS
36middle ear squamous cell carcinoma10.3HBA1, VIM
37lateral medullary syndrome10.3ENO2, NRAS
38appendix mucinous cystadenocarcinoma10.3HRAS, KRAS
39hypersensitivity reaction type ii disease10.3ENO2, TP53
40mixed endometrial stromal and smooth muscle tumor10.3ENO2, TP53
41nasal cavity adenocarcinoma10.3KRAS, KRT19, TP53
42tabes dorsalis10.3HRAS, KRAS
43bile duct disease10.3TP53, VWF
44breast intracanalicular fibroadenoma10.3HBA1, VWF
45neonatal stroke10.3HRAS, NRAS
46bullous keratopathy10.3CYP2E1, KRT19, TP53
47tooth erosion10.3HBA1, VIM
48malignant type ab thymoma10.3HBA1, VWF
49kidney cortex necrosis10.3ENO2, TP53
50bladder clear cell adenocarcinoma10.3ENO2, KRT19

Graphical network of the top 20 diseases related to Liver Angiosarcoma:



Diseases related to liver angiosarcoma

Symptoms & Phenotypes for Liver Angiosarcoma

About this section

GenomeRNAi Phenotypes related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00055-A-19.9CDK4, HRAS, KRAS, VIM

MGI Mouse Phenotypes related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

41 (show all 16)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011869.2CDK4, CDKN2A, KRAS, NRAS, TP53
2MP:00053709.0CDK4, CDKN2A, CYP2E1, KRAS, NRAS, TP53
3MP:00053888.7CDKN2A, ENO2, HRAS, KRAS, TP53, VIM
4MP:00053808.2CDK4, CDKN2A, KRAS, KRT19, NRAS, TP53
5MP:00053918.2CDK4, CDKN2A, KRAS, NRAS, TP53, VIM
6MP:00053818.2CDK4, CDKN2A, KRAS, KRT19, NRAS, TP53
7MP:00053798.1CDK4, CDKN2A, HRAS, KRAS, KRT19, NRAS
8MP:00107718.0CDK4, CDKN2A, HRAS, KRAS, KRT19, NRAS
9MP:00030128.0CDKN2A, HRAS, KRAS, KRT19, NRAS, TP53
10MP:00053767.9CDK4, CDKN2A, CYP2E1, HRAS, KRAS, NRAS
11MP:00053867.8CDK4, CDKN2A, CYP2E1, ENO2, HRAS, KRAS
12MP:00020067.7CDK4, CDKN2A, CYP2E1, HRAS, KRAS, KRT19
13MP:00053847.4CDK4, CDKN2A, ENO2, KRAS, KRT19, NRAS
14MP:00036317.2CDK4, CDKN2A, ENO2, HRAS, KRAS, KRT19
15MP:00053857.1CDK4, CDKN2A, CYP2E1, HRAS, KRAS, KRT19
16MP:00107687.1CDK4, CDKN2A, CYP2E1, HRAS, KRAS, KRT19

Drugs & Therapeutics for Liver Angiosarcoma

About this section

Drugs for Liver Angiosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MechlorethamineapprovedPhase 337751-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
 
KBioGR_001448
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
╬▓,╬▓'-dichlorodiethyl-N-methylamine
2
Doxorubicinapproved, investigationalPhase 3, Phase 1171423214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
3
IfosfamideapprovedPhase 33913778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide (JAN/USP/INN)
 
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
4
DoxilApproved June 1999Phase 3, Phase 1171431703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
5Antineoplastic Agents, AlkylatingPhase 34474
6Topoisomerase InhibitorsPhase 3, Phase 14945
7Isophosphamide mustardPhase 3391
8Anti-Bacterial AgentsPhase 3, Phase 110884
9Alkylating AgentsPhase 34694
10Antibiotics, AntitubercularPhase 3, Phase 16972
11ImmunoglobulinsPhase 16045
12AntibodiesPhase 16045
13Antibodies, MonoclonalPhase 13795
14Liver Extracts3868

Interventional clinical trials:

idNameStatusNCT IDPhase
1Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaUnknown statusNCT00346164Phase 3
2Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00720174Phase 1
3Identification, Molecular Epidemiology Angiosarcoma of the Liver FranceActive, not recruitingNCT01786889
4Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic CorrelationNot yet recruitingNCT03025438

Search NIH Clinical Center for Liver Angiosarcoma

Genetic Tests for Liver Angiosarcoma

About this section

Anatomical Context for Liver Angiosarcoma

About this section

MalaCards organs/tissues related to Liver Angiosarcoma:

36
Liver, Endothelial

FMA organs/tissues related to Liver Angiosarcoma:

17
The liver

Publications for Liver Angiosarcoma

About this section

Articles related to Liver Angiosarcoma:

(show all 18)
idTitleAuthorsYear
1
Liver Angiosarcoma: Rare tumour associated with a poor prognosis, literature review and case report. (27718433)
2016
2
Sequential development of hepatocellular carcinoma and liver angiosarcoma in a vinyl chloride-exposed worker. (27544804)
2016
3
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case report. (22280556)
2012
4
Widening spectrum of liver angiosarcoma in children. (21832953)
2011
5
Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. (12211074)
2002
6
Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma. (10952247)
2000
7
Liver angiosarcoma and hemangiopericytoma after occupational exposure to vinyl chloride monomer. (10964802)
2000
8
Diffuse liver angiosarcoma and cerebral cavernous angiomas in a young patient. (10692780)
1999
9
Two new cases of liver angiosarcoma: history and perspectives of liver angiosarcoma among plastic industry workers. (9284534)
1997
10
Vinylchloride monomer exposure by the plastic industry workers basic condition for liver angiosarcoma appearance. (9277092)
1996
11
Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. (1793483)
1991
12
Invasive character of malignant endothelial cells in vinyl-chloride-induced liver angiosarcoma. (2381457)
1990
13
Massive bleeding after fine needle aspiration of liver angiosarcoma. (2298353)
1990
14
Liver angiosarcoma in a vinyl chloride polymerization plant worker. Report of the seventh Italian case. (3173221)
1988
15
Iatrogenic disease. Lipoid pneumonia and liver angiosarcoma. (3714604)
1986
16
Two cases of liver angiosarcoma among polyvinyl chloride (PVC) extruders of an Italian factory producing PVC bags and other containers. (6539068)
1984
17
Log normal distribution of the incubation period of liver angiosarcoma in vinyl chloride polymerization workers. (569691)
1979
18
Persistence of DNA damage during development of liver angiosarcoma in rats fed dimethylnitrosamine. (570883)
1979

Variations for Liver Angiosarcoma

About this section

Expression for genes affiliated with Liver Angiosarcoma

About this section
Search GEO for disease gene expression data for Liver Angiosarcoma.

Pathways for genes affiliated with Liver Angiosarcoma

About this section

Pathways related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

(show top 50)    (show all 62)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.5CDKN2A, TP53
29.5CDKN2A, TP53
39.4HRAS, KRAS, NRAS
49.4HRAS, KRAS, NRAS
5
Show member pathways
9.4HRAS, KRAS, NRAS
6
Show member pathways
9.4HRAS, KRAS, NRAS
7
Show member pathways
9.4HRAS, KRAS, NRAS
8
Show member pathways
9.4HRAS, KRAS, NRAS
99.4HRAS, KRAS, NRAS
109.4HRAS, KRAS, NRAS
119.4HRAS, KRAS, NRAS
12
Show member pathways
9.4HRAS, KRAS, NRAS
13
Show member pathways
9.4HRAS, KRAS, NRAS
149.4HRAS, KRAS, NRAS
15
Show member pathways
9.4HRAS, KRAS, NRAS
16
Show member pathways
9.4HRAS, KRAS, NRAS
17
Show member pathways
9.4HRAS, KRAS, NRAS
189.4HRAS, KRAS, NRAS
199.4HRAS, KRAS, NRAS
20
Show member pathways
9.4HRAS, KRAS, NRAS
219.4HRAS, KRAS, NRAS
229.4CDK4, KRAS, TP53
23
Show member pathways
9.4CDK4, KRAS, TP53
249.4CDK4, TP53, VIM
259.1HRAS, KRAS, NRAS, VWF
269.1CDK4, CDKN2A, TP53
27
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
28
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
29
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
30
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
319.1HRAS, KRAS, NRAS, TP53
32
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
33
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
349.1HRAS, KRAS, NRAS, TP53
359.1HRAS, KRAS, NRAS, TP53
369.1HRAS, KRAS, NRAS, TP53
379.1HRAS, KRAS, NRAS, TP53
389.1HRAS, KRAS, NRAS, TP53
399.1HRAS, KRAS, NRAS, TP53
409.1HRAS, KRAS, NRAS, TP53
41
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
42
Show member pathways
9.1HRAS, KRAS, NRAS, TP53
439.0CDKN2A, HRAS, TP53
449.0CDK4, HRAS, KRAS, NRAS
45
Show member pathways
9.0CDK4, HRAS, KRAS, NRAS
469.0CDK4, HRAS, KRAS, NRAS
47
Show member pathways
9.0CDK4, HRAS, KRAS, NRAS
48
Show member pathways
8.8CDK4, CDKN2A, KRAS, TP53
498.8CDK4, CDKN2A, TP53, VIM
50
Show member pathways
8.7CDK4, HRAS, KRAS, NRAS, VIM

GO Terms for genes affiliated with Liver Angiosarcoma

About this section

Cellular components related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytosolGO:00058297.0CDK4, CDKN2A, ENO2, HBA1, HRAS, KRAS

Biological processes related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1regulation of long-term neuronal synaptic plasticityGO:004816910.3HRAS, KRAS
2positive regulation of cellular senescenceGO:200077410.2CDKN2A, KRAS
3epidermal growth factor receptor signaling pathwayGO:000717310.1HRAS, KRAS, NRAS
4ERBB2 signaling pathwayGO:003812810.1HRAS, KRAS, NRAS
5Fc-epsilon receptor signaling pathwayGO:003809510.1HRAS, KRAS, NRAS
6cellular senescenceGO:009039810.1CDKN2A, HRAS
7leukocyte migrationGO:005090010.1HRAS, KRAS, NRAS
8replicative senescenceGO:009039910.0CDKN2A, TP53
9cell cycle arrestGO:00070509.7CDKN2A, HRAS, TP53
10positive regulation of gene expressionGO:00106289.7HRAS, KRAS, TP53, VIM
11stimulatory C-type lectin receptor signaling pathwayGO:00022239.4HRAS, KRAS, NRAS
12Ras protein signal transductionGO:00072659.0CDKN2A, HRAS, KRAS, NRAS, TP53

Molecular functions related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein complex bindingGO:00324038.7CDK4, KRAS, KRT19, NRAS

Sources for Liver Angiosarcoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet